Vaccines

Oct 04, 2017
By Pharmaceutical Technology Editors
The Danish biotechnology company has been awarded a sole-source BARDA contract valued at more than $539 million for a freeze-dried smallpox vaccine.
Oct 04, 2017
By Pharmaceutical Technology Editors
Under Project BioShield, the agency could provide more than $170 million in funding to purchase and support late-stage development of Ebola vaccines and therapeutic drugs.
Oct 02, 2017
By Pharmaceutical Technology Editors
A grant from the Bill & Melinda Gates Foundation will advance PnuVax’s pneumonia vaccine’s clinical development and biomanufacturing scale-up using a low-cost manufacturing approach.
Sep 20, 2017
By Pharmaceutical Technology Editors
Under this partnership, Johnson & Johnson and BARDA will focus on the advanced development of a small-molecule drug and vaccine for the pandemic flu.
Sep 14, 2017
By Pharmaceutical Technology Editors
Shingrix represents a new, possibly better alternative to existing treatments.
Aug 28, 2017
By Pharmaceutical Technology Editors
FDA halts unproved stem-cell cancer treatments administered to California patients, which was derived from a commercially unavailable military-grade vaccine.
Aug 28, 2017
By Pharmaceutical Technology Editors
The acquisition of Protein Sciences, a vaccines biotechnology company, strengthens Sanofi’s influenza vaccines portfolio.
Aug 09, 2017
By Pharmaceutical Technology Editors
Through its life-sciences business, MilliporeSigma, Merck KGaA will collaborate with Baylor College of Medicine to advance vaccine development for neglected and emerging diseases.
Aug 09, 2017
By Pharmaceutical Technology Editors
FDA requests more detailed information on a post-marketing study for Dynavax’s hep-B vaccine, which will require an extended review time past its August 2017 PDUFA date.
Jul 31, 2017
By Pharmaceutical Technology Editors
Partnership aims to develop new vaccine regimens against hep B and HIV by combining respective proprietary vaccine technologies.
native1_300x100
lorem ipsum